学术探索
学术期刊
新闻热点
数据分析
智能评审

Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function

被引：42
作者：
Iversen, P
Melezinek, I
Schmidt, A
机构：
[1] Univ Copenhagen, Rigshosp, Dept Urol, DK-2100 Copenhagen, Denmark
[2] AstraZeneca, Med Affairs, Macclesfield, Cheshire, England
[3] Univ Stellenbosch, Dept Urol, ZA-7505 Tygerberg, South Africa
来源：
BJU INTERNATIONAL | 2001年 / 87卷 / 01期
关键词：
D O I：
10.1046/j.1464-410x.2001.00988.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：47 / 56
页数：10
相关论文
共 79 条
[1]  
ACKERMAN MD, 1994, SEXUAL DYSFUNCTION N, P229
[2]   FLUTAMIDE THERAPY FOR CARCINOMA OF PROSTATE [J].
AIRHART, RA ;
BARNETT, TF ;
SULLIVAN, JW ;
LEVINE, RL ;
SCHLEGEL, JU .
SOUTHERN MEDICAL JOURNAL, 1978, 71 (07) :798-801
[3]  
[Anonymous], BR J UROL S2
[4]   A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer [J].
Bales, GT ;
Chodak, GW .
UROLOGY, 1996, 47 (1A) :38-43
[5]   Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: Results of an Italian Prostate Cancer Project study [J].
Boccardo, F ;
Rubagotti, A ;
Borichello, M ;
Battaglia, M ;
Carmignani, G ;
Comeri, G ;
Conti, G ;
Cruciani, G ;
Dammino, S ;
Delliponti, U ;
Ditonno, P ;
Ferraris, V ;
Lilliu, S ;
Montefiore, F ;
Portoghese, F ;
Spano, G .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2027-2038
[6]   Are non-steroidal anti-androgens appropriate as monotherapy in advanced prostate cancer? [J].
Boccon-Gibod, L .
EUROPEAN UROLOGY, 1998, 33 (02) :159-164
[7]   Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma [J].
Studer, UE .
EUROPEAN UROLOGY, 1997, 32 (04) :395-396
[8]   Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate [J].
Brufsky, A ;
FontaineRothe, P ;
Berlane, K ;
Rieker, P ;
Jiroutek, M ;
Kaplan, I ;
Kaufman, D ;
Kantoff, P .
UROLOGY, 1997, 49 (06) :913-920
[9]  
BUFFUM J, 1986, J PSYCHOACTIVE DRUGS, V18, P97
[10]  
Cassileth B R, 1992, Qual Life Res, V1, P323, DOI 10.1007/BF00434946
12345678